Interim HealthCare Inc.

Health Technology, Healthcare Analytics

PRNewswire | May 31, 2023

Marpai, Inc. an artificial intelligence (AI)-powered healthcare payer transforming self-funded employer health plans, is proud to announce the launch of its innovative platform, Marpai Connect. Marpai Connect, an AI and data-driven matchmaking platform, actively pairs health plan members with an array of value-based providers. Marpai Connect offers self-insured employers a way to reduce risk and cost associated with their healthcare spending. Marpai Connect will be a core part o...

HIT Consultant | February 05, 2020

Verana Health, a technology company that is curating and analyzing real-world clinical data to advance patient care, today announced the close of a $100 million investment led by GV. New investors Bain Capital Ventures, Casdin Capital, and Define Ventures also participated in the round along with the company’s existing slate of investors. Renowned life sciences investor Brook Byers continues to serve as Chairman of Verana’s Board. Founded in 2008, Verana Health utilizes this real-wor...

Health Technology

Med Tech Solutions | September 09, 2021

Med Tech Solutions (MTS), provider of practice-centered IT solutions for healthcare organizations, has launched MTS Practice Data Analytics visual business intelligence (BI) tools. Practice Data Analytics delivers more than 40 standard BI reports from electronic health record (EHR) data that Acan be viewed in easily customized dashboards. Clinical, business, and IT practice leaders get intuitive, immediate insights into key performance indicators to guide decision-making and immediately addre...

MedCity News | January 15, 2020

Although it faced a setback earlier this month when regulators put the kibosh on its deal to acquire a rival company, genetic sequencing equipment maker Illumina will leave the J.P. Morgan Healthcare Conference with two new partnering deals under its belt. The San Diego-based company and Swiss drug and diagnostics maker Roche said Monday that they had formed a partnership to increase availability of genomic testing to patients with cancers. The 15-year, non-exclusive partnership is meant to broa...